Reliability and Performance Analysis of the Use of Tissue Flossing for Blood Flow Restriction.
Launched by PAULISTA UNIVERSITY · Oct 4, 2023
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Objectives: to evaluate the intra- and inter-rater reliability of the occlusion pressure generated by TF, investigate the reproducibility of TF application on different days and compare TF with traditional RFS in terms of muscle gains.
Methods: the study is divided into two stages: First stage, randomized controlled crossover clinical trial, 80 healthy individuals aged 18 to 30 years old evaluated to determine the reliability of the TF. Participants will follow one of two types of randomization, with exclusions based on health criteria. Assessments include anthropometric characteristics, d...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- * Individuals who present one or more of the following characteristics will not be included:
- • 1 presence of any health condition that contraindicates or prevents exercise;
- • 2 diabetes and diagnosed high blood pressure;
- • 3 inflammatory, psychiatric, cardiovascular and/or respiratory rheumatological disease; - -4 being dependent on alcohol, consuming drugs and/or being a smoker;
- • 5 history of knee surgery (e.g., meniscal repair and ligament reconstruction) or recent lower limb musculoskeletal injury that may impair performance during tests or interventions (e.g., muscle injury, tendinopathy, patellofemoral pain and/or back pain column in the last six months);
- • 6 use of ergogenic supplements to improve physical performance and/or muscle mass and/or vasoactive medications;
- • 7 having one or more risk factors predisposing to thromboembolism
- Exclusion Criteria:
- * Participants will be excluded from the study if they:
- • 1 have a health problem that does not allow them to continue;
- • 2 wish to leave the study;
- • 3 not sign the consent form
About Paulista University
Paulista University is a leading educational institution in Brazil, renowned for its commitment to advancing medical research and clinical practice. With a strong emphasis on innovation and interdisciplinary collaboration, the university conducts a variety of clinical trials aimed at enhancing patient care and contributing to the global body of medical knowledge. Its dedicated research teams, equipped with state-of-the-art facilities, focus on a wide range of therapeutic areas, ensuring rigorous methodologies and adherence to ethical standards. Paulista University's strategic partnerships with healthcare organizations and industry stakeholders further bolster its capacity to deliver impactful research outcomes that benefit both the scientific community and the wider public.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Presidente Prudente, Sp, Brazil
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported